Association of tumor-infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: analysis of the MEND study.
Saved in:
| Title: | Association of tumor-infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: analysis of the MEND study. |
|---|---|
| Authors: | Byemerwa J; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA., Neish D; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA., Forgah L; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA., Deveaux A; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA., Osazuwa-Peters O; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA., Joshi A; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA., Salako O; College of Medicine & Lagos University Teaching Hospital, University of Lagos, Lagos, Lagos State, Nigeria., Daramola A; College of Medicine, University of Lagos, Lagos, Lagos State, Nigeria., Alatise O; Obafemi Awolowo University Teaching Hospital, Ife-Ife, Osun State, Nigeria., Ogun G; University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria., Hall A; Department of Pathology, Duke University School of Medicine, Durham, NC, USA., Adeniyi A; Federal Medical Center, Abeokuta, Ogun State, Nigeria., Ayandipo O; University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria., Olajide T; College of Medicine & Lagos University Teaching Hospital, University of Lagos, Lagos, Lagos State, Nigeria., Olasehinde O; Obafemi Awolowo University Teaching Hospital, Ife-Ife, Osun State, Nigeria., Arowolo O; Obafemi Awolowo University Teaching Hospital, Ife-Ife, Osun State, Nigeria., Adisa A; Obafemi Awolowo University Teaching Hospital, Ife-Ife, Osun State, Nigeria., Afuwape O; University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria., Olusanya A; Obafemi Awolowo University Teaching Hospital, Ife-Ife, Osun State, Nigeria., Adegoke A; Our Lady of Apostle Catholic Hospital, Ibadan, Oyo State, Nigeria., Tollefsbol TO; University of Alabama at Birmingham, Birmingham, AL, USA., Arnett D; University of Kentucky, Lexington, KY, USA., Muehlbauer MJ; Duke Molecular Physiology Institute, Duke University, Durham, NC, USA., Akinyemiju T; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA. tomi.akinyemiju@duke.edu.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA. tomi.akinyemiju@duke.edu. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2026 Jul 10; Vol. 218 (1). Date of Electronic Publication: 2026 Jul 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
